AU2003263988A8 - Methods and compositions to treat conditions associated with neovascularization - Google Patents

Methods and compositions to treat conditions associated with neovascularization

Info

Publication number: AU2003263988A8
Authority: AU; Australia
Prior art keywords: neovascularization; compositions; methods; conditions associated; treat conditions
Prior art date: 2002-08-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003263988A

Other versions

AU2003263988A1 (en

Inventor

Dai Ren

Ming-Chung Wong

Kin-Ping Wong

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wackvom Ltd

Original Assignee

Wackvom Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-05

Filing date

2003-08-05

Publication date

2004-02-23

2003-08-05 Application filed by Wackvom Ltd filed Critical Wackvom Ltd

2004-02-23 Publication of AU2003263988A1 publication Critical patent/AU2003263988A1/en

2004-02-23 Publication of AU2003263988A8 publication Critical patent/AU2003263988A8/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003263988A 2002-08-05 2003-08-05 Methods and compositions to treat conditions associated with neovascularization Abandoned AU2003263988A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US40113002P	2002-08-05	2002-08-05
US60/401,130		2002-08-05
PCT/US2003/024455 WO2004012677A2 (en)	2002-08-05	2003-08-05	Methods and compositions to treat conditions associated with neovascularization

Publications (2)

Publication Number	Publication Date
AU2003263988A1 AU2003263988A1 (en)	2004-02-23
AU2003263988A8 true AU2003263988A8 (en)	2004-02-23

Family

ID=31495928

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003263988A Abandoned AU2003263988A1 (en)	2002-08-05	2003-08-05	Methods and compositions to treat conditions associated with neovascularization

Country Status (6)

Country	Link
EP (1)	EP1545493A4 (en)
JP (1)	JP2006508047A (en)
CN (1)	CN1723017A (en)
AU (1)	AU2003263988A1 (en)
TW (1)	TW200407119A (en)
WO (1)	WO2004012677A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1803468B1 (en) *	2003-12-22	2011-09-07	Novartis AG	Agents for treatment of glaucomatours retinopathy and optic neuropathy
ATE511836T1 (en) *	2005-04-29	2011-06-15	Univ Johns Hopkins	METHOD FOR SUPPRESSING SKIN CARCINOGENESIS INDUCED BY UV LIGHT
WO2007130353A2 (en) *	2006-05-01	2007-11-15	Johns Hopkins University	Phase 2 inducers, ppar-alpha agonists and related signalling pathways protect cartilage against inflammation, apoptosis and stress
WO2009051739A1 (en) *	2007-10-16	2009-04-23	Johns Hopkins University	Methods for protecting the skin from radiation insults
GB0811992D0 (en) *	2008-07-01	2008-08-06	Mithen Richard	Treatment
CA2958372C (en) *	2014-07-09	2020-05-05	Darlene E. MCCORD	Compositions for anti-inflammatory, antioxidant effects and improved respiratory function by specific histone deacetylase inhibition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411986A (en) *	1993-03-12	1995-05-02	The Johns Hopkins University	Chemoprotective isothiocyanates
GB2346325A (en) *	1999-02-02	2000-08-09	Wassen Int Ltd	Formulation comprising a brassica extract or sulforaphane and resveratrol
US6433011B1 (en)	2000-03-08	2002-08-13	American Health Foundation	Method for inhibiting formation of aberrant crypt foci in the colon of a mammal

2003
- 2003-08-05 JP JP2004526444A patent/JP2006508047A/en active Pending
- 2003-08-05 EP EP03767196A patent/EP1545493A4/en not_active Withdrawn
- 2003-08-05 CN CNA038237474A patent/CN1723017A/en active Pending
- 2003-08-05 WO PCT/US2003/024455 patent/WO2004012677A2/en not_active Ceased
- 2003-08-05 TW TW092121415A patent/TW200407119A/en unknown
- 2003-08-05 AU AU2003263988A patent/AU2003263988A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1545493A4 (en)	2006-01-11
WO2004012677A3 (en)	2005-02-24
TW200407119A (en)	2004-05-16
EP1545493A2 (en)	2005-06-29
AU2003263988A1 (en)	2004-02-23
CN1723017A (en)	2006-01-18
JP2006508047A (en)	2006-03-09
WO2004012677A2 (en)	2004-02-12

Similar Documents

Publication	Publication Date	Title
GB2423928B (en)	2008-04-09	Methods and compositions for treating pain
ZA200607433B (en)	2009-09-30	Methods and compositions for the treatment of gastroin-testinal disorders
IL181896A0 (en)	2007-07-04	Methods and compositions for the treatment of hyperlipidemia
IL208191A0 (en)	2010-12-30	Compositions and methods for treating rage-associated disorders
IL188420A0 (en)	2008-08-07	Methods and compositions with enhanced therapeutic activity
HUE045022T2 (en)	2019-12-30	Methods and compositions for treatment of water
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
EP1827362A4 (en)	2012-08-29	Compositions and methods of their use for improving the condition and appearance of skin
IL229039A0 (en)	2013-12-31	Solid compositions and methods for treating middle-of-the night insomnia
EP1703907A4 (en)	2009-03-25	Compositions and methods to treat recurrent medical conditions
AU2002230888A1 (en)	2002-06-24	Methods and compositions to treat conditions associated with neovascularization
GB0303609D0 (en)	2003-03-19	Novel therapeutic method and compositions
ZA200508655B (en)	2009-01-28	Compositions and methods relating to stop-1
GB0219568D0 (en)	2002-10-02	Improvements in and to compositions
EP1786265A4 (en)	2009-08-19	Novel compositions and methods of treatment
ZA200703087B (en)	2009-04-29	Methods and compositions for the treatment of hyperlipidemia
EP1670314A4 (en)	2009-02-25	Methods and compositions comprising diamines as new anti-tubercular therapeutics
AU2003263988A8 (en)	2004-02-23	Methods and compositions to treat conditions associated with neovascularization
EP1601348A4 (en)	2008-12-10	Compositions and methods with enhanced therapeutic activity
IL180195A0 (en)	2007-06-03	Aequorin-containing compositions and methods of using same
ZA200710205B (en)	2009-03-25	Solid compositions and methods for treating middle-of-the night insomnia
GB0418762D0 (en)	2004-09-22	Methods and compositions to treat glaucoma
GB0327050D0 (en)	2003-12-24	Therapeutic methods compositions and uses
AU2003257965A8 (en)	2004-03-19	Phosphonamide and phosphonamide blend compositions and method to treat water
EP1660114A4 (en)	2008-06-25	Methods and compositions for treating disorders of the extracellular matrix

Legal Events

Date	Code	Title	Description
2005-06-09	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase